Genetic polymorphisms in promoter and intronic regions of CYP1A2 gene in Roma and Hungarian population samples

被引:5
作者
Szalai, Renata [1 ,2 ]
Magyari, Lili [1 ,2 ]
Matyas, Petra [1 ]
Duga, Balazs [1 ,2 ]
Banfai, Zsolt [1 ]
Szabo, Andras [1 ]
Kovesdi, Erzsebet [1 ,2 ]
Melegh, Bela [1 ,2 ]
机构
[1] Univ Pecs, Ctr Clin, Dept Med Genet, H-7624 Pecs, Hungary
[2] Univ Pecs, Szentagothai Res Ctr, H-7624 Pecs, Hungary
关键词
CYP1A2; Polymorphisms; Pharmacogenetics; Roma; Hungarian; Interethnic; LUNG-CANCER RISK; THEOPHYLLINE METABOLISM; HEALTH-STATUS; ASSOCIATION; PREVALENCE; HAPLOTYPES; CLOZAPINE; PHENOTYPE; ATTITUDES; CAFFEINE;
D O I
10.1016/j.etap.2014.09.012
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The purpose of this study was to determine the interethnic differences of four CYP1A2 drug metabolizing enzyme variants. A total of 404 Roma and 396 Hungarian healthy subjects were genotyped for -163C>A, -729C>T, -2467delT and -3860G>A variants of CYP1A2 by RT-PCR and PCR-RFLP technique. The -3860A and -729T allele were not detectable in Roma samples, while in Hungarian samples were present with 2.02% and 0.25% prevalence, respectively. There was a 1.5-fold difference in presence of homozygous 163AA genotype between Hungarian and Roma samples (49.5% vs. 31.9%, p < 0.001). The -163A allele frequency was 68.6% in Hungarians and 56.9% in Romas (p = 0.025). The -2467delT allele frequency was 6.81% in Roma group and 5.81% in Hungarians. The most frequent allelic constellation was -3860G/-2467T/-729C/-163A in both populations. In conclusion, Hungarians have markedly elevated chance for rapid metabolism of CYP1A2 substrates, intensified procarcinogen activation and increased risk for cancers. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:814 / 820
页数:7
相关论文
共 37 条
[1]   Genetic polymorphism of CYP1A2 in ethiopians affecting induction and expression: Characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1 [J].
Aklillu, E ;
Carrillo, JA ;
Makonnen, E ;
Hellman, K ;
Pitarque, M ;
Bertilsson, L ;
Ingelman-Sundberg, M .
MOLECULAR PHARMACOLOGY, 2003, 64 (03) :659-669
[2]   CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population [J].
B'chir, Fatma ;
Pavanello, Sofia ;
Knani, Jalel ;
Boughattas, Sami ;
Arnaud, Maurice J. ;
Saguem, Saad .
LIFE SCIENCES, 2009, 84 (21-22) :779-784
[3]  
Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3
[4]  
Dandara C, 2011, PHARMACOGENOMICS, V12, P1663, DOI [10.2217/PGS.11.106, 10.2217/pgs.11.106]
[5]   Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2-163C&gt;A polymorphism [J].
Djordjevic, Natasa ;
Ghotbi, Roza ;
Jankovic, Slobodan ;
Aklillu, Eleni .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (07) :697-703
[6]  
Dobranici M, 2012, J Med Life, V5, P382
[7]   Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans [J].
Ghotbi, Roza ;
Christensen, Magnus ;
Roh, Hyung-Keun ;
Ingelman-Sundberg, Magnus ;
Aklillu, Eleni ;
Bertilsson, Leif .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) :537-546
[8]   Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population [J].
Hamdy, SI ;
Hiratsuka, M ;
Narahara, K ;
Endo, N ;
El-Enany, M ;
Moursi, N ;
Ahmed, MSE ;
Mizugaki, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (03) :321-324
[9]   Inducibility of CYP1A2 by orneprazole in vivo related to the genetic polymorphism of CYP1A2 [J].
Han, XM ;
Ouyang, DS ;
Chen, XP ;
Shu, Y ;
Jiang, CH ;
Tan, ZR ;
Zhou, HH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (05) :540-543
[10]   Clinically Significant Drug Interactions with Atypical Antipsychotics [J].
Kennedy, William Klugh ;
Jann, Michael W. ;
Kutscher, Eric C. .
CNS DRUGS, 2013, 27 (12) :1021-1048